Classification
GHRH-analog research peptide
Classification organizes the research catalogue. It is not a claim of safety, efficacy, or approved use.
For Research Use Only · Not For Human or Veterinary Use · UK Research Compounds

GHRH-analog research peptide, standard concentration.
GHRH-analog research peptide, standard concentration.
Tesamorelin 10mg vial supplied for laboratory analytical research. 99.86% purity verified by independent third-party testing.
EVLV fulfills research products from the United States and publishes product-specific batch documentation when a matching laboratory report is available. Testing methods and results are specific to the product and batch identified in each report.
This product is supplied in the format shown on this page: lyophilized powder.
For laboratory research use only. Not for human or veterinary use.
Compound research context
The catalogue CAS reference for Tesamorelin is 218949-48-5. Classification and CAS information identify the intended compound but do not replace exact product and lot verification.
Open the complete Tesamorelin research hubClassification
Classification organizes the research catalogue. It is not a claim of safety, efficacy, or approved use.
Analytical review
Match the named compound, labeled strength, sample or lot identifier, laboratory, and analysis date. Review the stated method for purity and any separate identity or measured-content result included in the record.
Available strengths
Product-specific questions
Tesamorelin is classified as a GHRH-analog research peptide. That classification is descriptive and is not a statement of an approved use.
The report states the sample identity, methods, and results supplied by the issuing laboratory. It applies only to the identified sample or lot.
No. EVLV support is limited to product identity, documentation, unopened-product storage, shipping, and institutional inquiries.